MPMichael A. Padula

Michael A. Padula

*This is an algorithmically generated author record based on publicly available information.

Michael A. Padula has a total of 186 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Congenital heart disease confers gestational age–dependent risks of mortality and morbidity in preterm infants

    by Paulomi M. Chaudhry, Nathaly Sweeney, Isabella Zaniletti, Louis J. Martin, Erika M. Edwards, Sharada H. Gowda, Michael Padula, Karna Murthy, Theresa R. Grover, Sarah U. Morton, et al.

  • Open Access

    Predicting risk of infection in infants with gastroschisis

    by Stefanie Riddle, Isabella Zaniletti, Karna Murthy, Alaina Pyle, Ellen Bendel-Stenzel, Elizabeth Jacobson, Theresa Grover, Heidi Karpen, Franscesca Miquel-Verges, Sadie Williams, et al.

    Objective: Identify clinical predictors of bloodstream (BSI) and urinary tract infections (UTI) in infants with gastroschisis. Study design: Retrospective analysis of infants with gastroschisis admitted to 47 neonatal intensive care units (NICUs) contributing to the Children’s Hospitals Neonatal Database (CHND) from 2010–23. Outcomes were occurrence of BSI or UTI before discharge. Generalized linear models with generalized estimating equation (GEE) to account for hospitals as clusters utilized to identify factors independently related to the outcomes. Result: Of 3987 eligible infants, rates of early BSI (within 3 days of birth) were 0.4%, any BSI 7.6% and UTI 3.5%. Median age of infection was 32 days for BSI and 39 days for UTI. Bowel atresia, silo/staged closure, patch closure, and additional anomalies were independently associated with these infections. Conclusion: We identified clinical predictors of BSI and UTI, which should facilitate limitation of antibiotic use in low risk patients.

  • CAKUT calculator: a clinical risk prediction tool for in-hospital mortality in neonates with congenital anomalies of the kidney and urinary tract admitted to level IV NICUs

    by Jennifer A. Rumpel, Isabella Zaniletti, Christine Stoops, Courtney P. Verscaj, Matthew W. Harer, Andrew M. South, Catherine Joseph, Semsa Gogcu, Mary Revenis, Mona Khattab, et al.

  • A multicenter descriptive study of neonatal-onset urea cycle disorder patients hospitalized in level IV NICUs

    by Whitney S. Thompson, Ellen M. Bendel-Stenzel, Isabella Zaniletti, Theresa R. Grover, Karna Murthy, Michael A. Padula, Queenie K. G. Tan, Kristen R. Suhrie

    Objective The objective of this study was to characterize the neonatal intensive care unit (NICU) course and outcomes for infants with neonatal-onset urea cycle disorders (UCDs). Study design Using the multicenter Children’s Hospitals Neonatal Database, a descriptive, retrospective cohort study was performed to characterize the presentation, interventions, comorbidities, and hospital outcomes for 176 patients with neonatal-onset UCDs that required level IV NICU care. Results The median age of presentation was 5 [3,7] days, with 167 (95%) infants requiring transfer to a level IV NICU. Renal replacement therapy was undertaken for at least 34 (20%) patients. Neurologic complications occurred most frequently, with 71 (40%) patients affected. Twenty-one (12%) infants experienced in-hospital mortality. Interventions, complications, and mortality were observed most frequently in the ornithine transcarbamylase deficiency group. Conclusion Neonatal-onset UCDs are associated with significant morbidity and mortality, but heterogeneity exists among the specific named UCDs.


  • Inter-center variations in length of hospitalization for infants with congenital jejunal or ileal atresia

    by Katie A. Huff, Isabella Zaniletti, Kera McNelis, Alan Ladd, Abeer Azzuqa, Carl H. Coghill, Daniel T. Robinson, Muralidhar H. Premkumar, Patricia W. Denning, Jae Kim, et al.

    Objective To quantify inter-center variation (ICV) in length of stay (LOS) among surviving infants with jejunal (JA) or ileal atresia (IA). Study design Children’s Hospitals Neonatal Consortium’s database was used to identify infants with JA or IA. After excluding infants with abdominal wall defects, survivors’ hospital LOS was modeled as a function of center using generalized linear models with log link for gamma distribution. Results There were 1134 and 808 infants with JA and IA, respectively. LOS had significant ICV in unadjusted (JA: 5.4 [IQR 3.7,9.9] weeks; IA: 4.3 [IQR 2.4,11.4] weeks) and multivariable analyses (JA: 4+ fold difference (6.5–31.5 week); p < 0.001 IA: 8+ fold difference (1.7–14.6 weeks); p < 0.001) with modifiable risk factors including cholestasis, ostomy creation, blood stream infection, and residual bowel length <55 cm. Conclusion Risk-adjusted ICV in LOS was observed in infants with JA and IA, which exposes opportunities for improvements in outcomes for infants with intestinal atresia.

  • A comparison of newer classifications of bronchopulmonary dysplasia: findings from the Children’s Hospitals Neonatal Consortium Severe BPD Group

    by Shilpa Vyas-Read, J. Wells Logan, Alain C. Cuna, Joana Machry, Kristin T. Leeman, Rebecca S. Rose, Michel Mikhael, Erica Wymore, John W. Ibrahim, Robert J. DiGeronimo, et al.

    Objective To compare three bronchopulmonary dysplasia (BPD) definitions against hospital outcomes in a referral-based population. Study design Data from the Children’s Hospitals Neonatal Consortium were classified by 2018 NICHD, 2019 NRN, and Canadian Neonatal Network (CNN) BPD definitions. Multivariable models evaluated the associations between BPD severity and death, tracheostomy, or length of stay, relative to No BPD references. Results Mortality was highest in 2019 NRN Grade 3 infants (aOR 225), followed by 2018 NICHD Grade 3 (aOR 145). Infants with lower BPD grades rarely died (<1%), but Grade 2 infants had aOR 7–21-fold higher for death and 23–56-fold higher for tracheostomy. Conclusions Definitions with 3 BPD grades had better discrimination and Grade 3 2019 NRN had the strongest association with outcomes. No/Grade 1 infants rarely had severe outcomes, but Grade 2 infants were at risk. These data may be useful for counseling families and determining therapies for infants with BPD.


  • Utility of echocardiography in predicting mortality in infants with severe bronchopulmonary dysplasia

    by Shilpa Vyas-Read, Erica M. Wymore, Isabella Zaniletti, Karna Murthy, Michael A. Padula, William E. Truog, William A. Engle, Rashmin C. Savani, Sushmita Yallapragada, J. Wells Logan, et al.

    Objective To determine the relationship between interventricular septal position (SP) and right ventricular systolic pressure (RVSP) and mortality in infants with severe BPD (sBPD). Study design Infants with sBPD in the Children’s Hospitals Neonatal Database who had echocardiograms 34–44 weeks’ postmenstrual age (PMA) were included. SP and RVSP were categorized normal, abnormal (flattened/bowed SP or RVSP > 40 mmHg) or missing. Results Of 1157 infants, 115 infants (10%) died. Abnormal SP or RVSP increased mortality (SP 19% vs. 8% normal/missing, RVSP 20% vs. 9% normal/missing, both p < 0.01) in unadjusted and multivariable models, adjusted for significant covariates (SP OR 1.9, 95% CI 1.2–3.0; RVSP OR 2.2, 95% CI 1.1–4.7). Abnormal parameters had high specificity (SP 82%; RVSP 94%), and negative predictive value (SP 94%, NPV 91%) for mortality. Conclusions Abnormal SP or RVSP is independently associated with mortality in sBPD infants. Negative predictive values distinguish infants most likely to survive.


  • Open Access

    Neonatal platelet count trends during inhaled nitric oxide therapy

    by Christopher S Thom, Matthew Devine, Stacey Kleinman, Erik A Jensen, Michele P Lambert, Michael A Padula

    Recent debate has focused on the significance of platelets generated in lung tissue. Here, we retrospectively analyzed platelet count changes in neonates requiring inhaled nitric oxide (iNO) pulmonary vasodilation therapy for pulmonary hypertension. There were no clinically significant changes in platelet count upon iNO initiation or during iNO therapy. Unexpectedly, platelet counts increased after iNO cessation. These findings argue against a clinically meaningful untapped pulmonary repository of megakaryocytes and platelets in this context, although acute platelet count increases might be expected after discontinuing iNO in some patients. Further work is needed to clarify the underlying etiology for these observations, and to better delineate the mechanisms for platelet count increases after recovery from lung injury.

  • The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year

    by Joanne M. Lagatta, Erik B. Hysinger, Isabella Zaniletti, Erica M. Wymore, Shilpa Vyas-Read, Sushmita Yallapragada, Leif D. Nelin, William E. Truog, Michael A. Padula, Nicolas F.M. Porta, et al.


  • Top Cited Papers

    Tracheobronchomalacia Is Associated with Increased Morbidity in Bronchopulmonary Dysplasia

    by Erik B. Hysinger, Nicholas L. Friedman, Michael A. Padula, Russell T. Shinohara, Huayan Zhang, Howard B. Panitch, Steven M. Kawut, Children's Hospitals Neonatal Consortium

    Rationale: Tracheobronchomalacia (TBM) is a common comorbidity in neonates with bronchopulmonary dysplasia (BPD). However, the effect of TBM on the clinical course of BPD is not well understood. Objectives: We sought to assess the impact of TBM on outcomes in neonates with BPD in a large, multicenter cohort. Methods: We performed a cohort study of 974 neonates with BPD admitted to 27 neonatal intensive care units participating in the Children’s Hospital Neonatal Database who had undergone bronchoscopy. In-hospital morbidity for neonates with BPD and TBM (n = 353, 36.2%) was compared with those without TBM (n = 621, 63.8%) using mixed-effects multivariate regression. Results: Neonates with TBM and BPD had more comorbidities, such as gastroesophageal reflux (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.23–2.29; P = 0.001) and pneumonia (OR, 1.68; 95% CI, 1.21–2.33; P = 0.002), and more commonly required surgeries, such as tracheostomy (OR, 1.55; 95% CI, 1.15–2.11; P = 0.005) and gastrostomy (OR, 1.38; 95% CI: 1.03–1.85; P = 0.03), than those without TBM. Neonates with TBM were hospitalized (118 ± 93 d vs. 105 ± 83 d; P = 0.02) and ventilated (83.1 ± 91.1 d vs. 67.2 ± 71.9 d; P = 0.003) longer than those without TBM. On discharge, neonates with TBM and BPD were more likely to be mechanically ventilated (OR, 1.37; 95% CI, 1.01–1.87; P = 0.045) and possibly less likely to receive oral nutrition (OR, 0.69; 95% CI, 0.47–1.01; P = 0.058). Conclusions: TBM is common in neonates with BPD who undergo bronchoscopy and is associated with longer and more complicated hospitalizations.